222
Participants
Start Date
May 6, 2019
Primary Completion Date
February 26, 2020
Study Completion Date
March 6, 2020
CR845 0.5 mcg/kg
IV CR845 0.5 mcg/kg administered three times/week
Cara Therapeutics Study Site, Great Neck
Cara Therapeutics Study Site, Philadelphia
Cara Therapeutics Study Site, Spartanburg
Cara Therapeutics Study Site, Albany
Cara Therapeutics Study Site, Hollywood
Cara Therapeutics Study Site, Coral Gables
Cara Therapeutics Study Site, Miami
Cara Therapeutics Study Site, Fort Lauderdale
Cara Therapeutics Study Site 2, Tampa
Cara Therapeutics Study Site, Tampa
Cara Therapeutics Study Site, Knoxville
Cara Therapeutics Study Site, Roseville
Cara Therapeutics Study Site, Minneapolis
Cara Therapeutics Study Site, Kansas City
Cara Therapeutics Study Site, Mesquite
Cara Therapeutics Study Site, Duncanville
Cara Therapeutics Study Site, Greenville
Cara Therapeutics Study Site, Mansfield
Cara Therapeutics Study Site, Temple
Cara Therapeutics Study Site 2, San Antonio
Cara Therapeutics Study Site, San Antonio
Cara Therapeutics Study Site 3, San Antonio
Cara Therapeutics Study Site, Austin
Cara Therapeutics Study Site, Denver
Cara Therapeutics Study Site, Las Vegas
Cara Therapeutics Study Site 2, Las Vegas
Cara Therapeutics Study Site, Escondido
Cara Therapeutics Study Site, San Diego
Cara Therapeutics Study Site, Victorville
Cara Therapeutics Study Site, Riverside
Cara Therapeutics Study Site, Middlebury
Cara Therapeutics Study Site, Norwich
Cara Therapeutics Study Site, Boston
Cara Therapeutics Study Site, Havlíčkův Brod
Cara Therapeutics Study Site, Nové Město na Moravě
Cara Therapeutics Study Site, Prague
Cara Therapeutics Study Site, Sokolov
Cara Therapeutics Study Site 2, Budapest
Cara Therapeutics Study Site, Budapest
Cara Therapeutics Study Site, Dunaújváros
Cara Therapeutics Study Site, Kaposvár
Cara Therapeutics Study Site, Kistarcsa
Cara Therapeutics Study Site, Nyíregyháza
Cara Therapeutics Study Site, Szombathely
Cara Therapeutics Study Site, Ostrołęka
Cara Therapeutics Study Site, Radom
Cara Therapeutics Study Site, Sochaczew
Lead Sponsor
Cara Therapeutics, Inc.
INDUSTRY